Cytogen, Inc. (KOSDAQ:217330)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,675.00
+5.00 (0.14%)
At close: Aug 11, 2026

Cytogen Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
12,98110,99131,20154,83815,87830,288
Short-Term Investments
12,02420,52210,06549.4650.435,515
Trading Asset Securities
----1,993-
Cash & Short-Term Investments
25,00631,51341,26654,88717,92235,803
Cash Growth
-35.26%-23.64%-24.82%206.26%-49.94%-
Accounts Receivable
6,3956,0813,700473.96588.2388.9
Other Receivables
370.39566.58836.34259.88164.15137.48
Receivables
6,7656,6474,536733.84752.38226.38
Inventory
4,2914,3891,72325.3131.47-
Prepaid Expenses
170.84155.94184.8234.71186.7373.13
Other Current Assets
1,317522.66368.71122.29396.767,487
Total Current Assets
37,55043,22848,07956,00319,38943,589
Property, Plant & Equipment
6,5326,3766,8284,9803,1042,808
Long-Term Investments
1,5571,5572,4895,5277,3317,321
Goodwill
4,8254,8254,8252,7235,712-
Other Intangible Assets
4,9695,0558,6244,8305,3101,496
Long-Term Deferred Tax Assets
706.56691.24884.61---
Other Long-Term Assets
899.71507.32748.49386.96375.1313.75
Total Assets
57,04062,24072,47874,45041,22055,528

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
2,1823,4571,666206.64189.2112.63
Accrued Expenses
781.44614.95843.76730.431,006376.4
Short-Term Debt
3,3474,771327.927,98025,7583,280
Current Portion of Leases
429428.71917556.4474.98442.66
Other Current Liabilities
4,1815,477960.51,2746,5022,579
Total Current Liabilities
10,92114,7494,71510,74733,9306,791
Long-Term Debt
11,04610,71513,2778,371-20,445
Long-Term Leases
585.93364.73349.93669.13191.3456.46
Pension & Post-Retirement Benefits
262.77139.93235.5937.0552.62191.07
Long-Term Deferred Tax Liabilities
---549.23838.98-
Other Long-Term Liabilities
114.03279.034,958721.58551.384,635
Total Liabilities
22,92926,24723,53521,09535,56432,519

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
11,56511,56511,56511,1398,9342,947
Additional Paid-In Capital
116,926117,434118,236107,52350,75954,635
Retained Earnings
-98,804-97,532-85,189-68,072-52,302-33,531
Treasury Stock
-3,234-3,234-3,234-3,234-3,234-3,234
Comprehensive Income & Other
7,2167,3297,2055,9981,5002,192
Total Common Equity
33,66935,56248,58353,3555,65623,009
Minority Interest
441.89430.51359.78---
Shareholders' Equity
34,11135,99348,94353,3555,65623,009
Total Liabilities & Equity
57,04062,24072,47874,45041,22055,528

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
15,40816,27914,87217,57626,42424,624
Net Cash (Debt)
9,59815,23326,39537,311-8,50211,179
Net Cash Growth
-59.29%-42.29%-29.26%---
Net Cash Per Share
416.14660.311168.852040.21-481.37659.73
Filing Date Shares Outstanding
23.1323.1323.0722.2217.8117.5
Total Common Shares Outstanding
23.1323.1323.0722.2217.8117.5
Working Capital
26,62928,47943,36445,256-14,54136,798
Book Value Per Share
1455.861537.712105.942401.36317.611314.64
Tangible Book Value
23,87525,68235,13345,803-5,36521,513
Tangible Book Value Per Share
1032.351110.461522.942061.45-301.261229.19
Land
302.68286.98294257.88--
Buildings
3,1742,1952,2491,973--
Machinery
4,7894,6442,080852.03969.67432.63
Construction In Progress
--26.41465.06507.95